Novel, orally active iron chelator APO-363: preclinical pharmacokinetics reported at AAPS Nov. 7, 2000 No Comments
Alkermes completes patient enrollment in clinical trial of new treatment for alcoholism Oct. 3, 2000 No Comments
RSS